Sriraam Kalingarayar, Amar Nandhakumar, Arumugam S Thennavan
Indian Journal of Anaesthesia 2017 61(12):1009-1011
The introduction of new chemotherapeutic agents for the treatment of multiple myeloma (MM) has improved the life expectancy and quality of life for these patients in the last decade. Therefore, more patients with MM are being treated for repeated pathological fractures. The anaesthesiologist should continue the optimum supportive care received by these patients in the perioperative period also, by understanding the pathophysiology of the disease, the adverse effects of the chemotherapeutic agents and the guidelines for their supportive care. We report the perioperative management of a patient with MM and discuss the perioperative anaesthetic considerations.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nY65Ca
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου